These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 823336)

  • 1. "Side" effects: a misnomer.
    Joyce CR
    J Med Ethics; 1976 Sep; 2(3):112-7. PubMed ID: 823336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doctors, nurses, pharmacists and patients--the Rational Evaluation and Choice in Hypertension (REACH) survey of hypertension care delivery.
    Lip GY; Beevers DG
    Blood Press Suppl; 1997; 1():6-10. PubMed ID: 9285101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse effects of drugs. Compiled and evaluated by the Committee on Drugs].
    Ochsenfahrt H
    Fortschr Med; 1984 Apr; 102(13):355-60. PubMed ID: 6724463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing surveillance of licensed medicinal and other products.
    Griffin JP
    Health Trends; 1981 Aug; 13(3):85-8. PubMed ID: 10258571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A drug information system. The patients' responses.
    Trollor J
    Aust Fam Physician; 1989 Jan; 18(1):28-30. PubMed ID: 2730442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational prescribing of drugs.
    Venulet J
    Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):151-4. PubMed ID: 404263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Information on drugs and drug hazards--a task of professional policy].
    Kimbel KH
    Med Klin; 1975 Oct; 70(44):1790-2. PubMed ID: 1186584
    [No Abstract]   [Full Text] [Related]  

  • 16. [Economic aspects of pharmacovigilance in the pharmaceutical industry].
    Abadie E; Souetre E
    Therapie; 1993; 48(2):125-7. PubMed ID: 8351680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing the risks of off-licence prescribing in pregnancy.
    Shah S; van Geijn H
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):156-9. PubMed ID: 17046143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ranking the efficacy of drugs--a question of "class"? It is difficult to determine equivalency of two different treatments].
    Liedholm H; Linné AB
    Lakartidningen; 2002 Sep; 99(36):3492-4, 3497-9, 3502. PubMed ID: 12362748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of efficacy and adverse effects in the (European) registration of drugs: what does it mean for the doctor and patient?].
    Koopmans PP; de Graeff PA; van Zwieten-Boot BJ; Lekkerkerker JF; Broekmans AW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(16):756-61. PubMed ID: 10812445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.